Quince Therapeutics, Inc. (IRLA): DEFA14A filed Oct 2, 2026

Form type

DEFA14A

Filing date

Oct 2, 2026

Accession number

0001193125-26-411262

Filer

Quince Therapeutics, Inc. (CIK 1662774)